4//SEC Filing
Akamine Scott 4
Accession 0000899243-21-021801
CIK 0001805387other
Filed
Jun 2, 8:00 PM ET
Accepted
Jun 3, 4:34 PM ET
Size
5.6 KB
Accession
0000899243-21-021801
Insider Transaction Report
Form 4
Akamine Scott
Chief Legal Officer
Transactions
- Award
Stock Option (Right to Buy)
2021-06-01+281,762→ 281,762 totalExercise: $13.17Exp: 2031-06-01→ Common Stock (281,762 underlying)
Footnotes (1)
- [F1]25% of the shares subject to this option shall vest and become exercisable on June 1, 2022, with the remainder vesting in thirty-six (36) equal monthly installments thereafter.
Documents
Issuer
Cerevel Therapeutics Holdings, Inc.
CIK 0001805387
Entity typeother
Related Parties
1- filerCIK 0001816720
Filing Metadata
- Form type
- 4
- Filed
- Jun 2, 8:00 PM ET
- Accepted
- Jun 3, 4:34 PM ET
- Size
- 5.6 KB